NCT04301076 2026-05-13Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)National Cancer Institute (NCI)Phase 1 Suspended30 enrolled